Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

      Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

      Farhat Nasim10 Jun 2019 9:30 AM IST
      Roche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
      Merck, Rigaku partner to develop novel molecular structure analysis technology

      Merck, Rigaku partner to develop novel molecular structure analysis technology

      Farhat Nasim10 Jun 2019 9:15 AM IST
      The partnership creates an outstanding strategic opportunity for both companies, Merck and Rigaku to establish leading products for chemical...
      Global forum to examine use of safer nicotine products

      Global forum to examine use of safer nicotine products

      Farhat Nasim10 Jun 2019 9:00 AM IST
      The forum will examine the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses.New Delhi: Amid a...
      GSK Nucala wins USFDA approval for two new self-administration options

      GSK Nucala wins USFDA approval for two new self-administration options

      Farhat Nasim9 Jun 2019 10:00 AM IST
      Nucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
      Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

      Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

      Farhat Nasim9 Jun 2019 9:25 AM IST
      Marie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...
      Caught On Camera: Chemist being thrashed by Politician for not welcoming him

      Caught On Camera: Chemist being thrashed by Politician for not welcoming him

      Farhat Nasim8 Jun 2019 12:55 PM IST
      Bihar: Misuse of political clout has come to the fore as a brother of a former Bihar minister and BJP national vice president was recently caught on...
      CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

      CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

      Farhat Nasim6 Jun 2019 12:11 PM IST
      New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
      India calls for expanding antiretroviral therapy coverage to combat HIV/AIDS

      India calls for expanding antiretroviral therapy coverage to combat HIV/AIDS

      Farhat Nasim6 Jun 2019 9:22 AM IST
      In India, a landmark HIV and AIDS (Prevention and Control) Act came into force from September 10 last year that provides a rights-based framework to...
      Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

      Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

      Farhat Nasim5 Jun 2019 10:00 AM IST
      Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
      NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

      NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

      Farhat Nasim4 Jun 2019 5:44 PM IST
      New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
      Dr Reddys Labs relaunches Zenatane-generic version of Accutane in US

      Dr Reddys Labs relaunches Zenatane-generic version of Accutane in US

      Farhat Nasim4 Jun 2019 11:52 AM IST
      Zenatane (lsotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg is being launched with an approved Risk Evaluation and Mitigation Strategy (REMS)...
      Cadila Healthcare gets 11 USFDA observations for St Louis facilities

      Cadila Healthcare gets 11 USFDA observations for St Louis facilities

      Farhat Nasim3 Jun 2019 5:23 PM IST
      The United States Food and Drug Administration (USFDA) inspected the manufacturing facilities of Nesher Pharmaceuticals (USA) LLC located at St Louis,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok